Trials / Completed
CompletedNCT01549743
The Pharmacokinetic Interaction Between Celecoxib and Rebamipide
Clinical Trial to Assess the Pharmacokinetic Interaction Between Celecoxib and Rebamipide in Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Hanlim Pharm. Co., Ltd. · Industry
- Sex
- Male
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This clinical trial aims to assess the pharmacokinetic interaction between celecoxib and rebamipide in healthy male subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Celecoxib | Celecoxib 200mg will be administered orally twice a day for 3 days |
| DRUG | Rebamipide | Rebamipide 100mg will be administered orally three times a day for 3 days |
| DRUG | Celecoxib plus Rebamipide | Celecoxib plus Rebamipide same way as "arm: celecoxib" and "arm: rebamipide" |
Timeline
- Start date
- 2012-05-09
- Primary completion
- 2012-06-13
- Completion
- 2012-06-13
- First posted
- 2012-03-09
- Last updated
- 2018-08-17
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01549743. Inclusion in this directory is not an endorsement.